AnPac Bio Class III Medical Device Passes NMPA Registration Tests And Will Start Clinical Trial In Q1, 2022
AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (ANPC), a US and China-based biotechnology company focused on early cancer screening and detection, announced today
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
BioCardia (NASDAQ:BCDA) shares rose 29.91% to $2.91 during Wednesday's after-market session. At the close, BioCardia's trading volume reached 793.9K shares. This is 471.05% of its average volume over the last 100 days. The company's market cap stands at $49.0 million.
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Rani Therapeutics Hldgs (NASDAQ:RANI) stock rose 7.36% to $35.0 during Wednesday's after-market session. The company's market cap stands at $690.0 million. As per the news, the Q3 earnings report came out 2 days ago.
76 Biggest Movers From Yesterday
Gainers
Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share.
55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
RenovoRx, Inc. (NASDAQ: RNXT) shares jumped 128% to $12.41. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a potential innovative treatment for pancreatic cancer.
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
AnPac Bio Announces Study Shows Strong Correlation Between CDA Score And Risk Of Cancer And Diseases
AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC, &ldquo, AnPac Bio, &rdquo, the &ldquo, Company&rdquo, or &ldquo, we&rdquo, )), a biotechnology company with operations in China and the United States focused on early
